Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/24 16:26 | 1/29/24 | TRML | Health | BioPrd | Biological Products, (No Diag | McDade Mark | WA | D | 1 | P | 3,250 | 32.50 | 0 | 100 | 16 | 742 | I | |||||||||||||||
11/20/23 18:15 | 11/17/23 | TRML | Health | BioPrd | Biological Products, (No Diag | Kulkarni Sandeep Chidambar | NY | DO | CEO | 2 | P.m | 179 | 13.10 | 0 | 14 | 2 | 730 | D | ||||||||||||||
11/20/23 18:14 | 11/17/23 | TRML | Health | BioPrd | Biological Products, (No Diag | Thiara Parvinder | NY | D | 2 | P.m | 95 | 11.86 | 0 | 8 | 11 | 84 | D | |||||||||||||||
10/27/23 17:43 | 10/25/23 | TRML | Health | BioPrd | Biological Products, (No Diag | Castelein Caley | NY | D | 1 | P.m | 281 | 14.03 | 0 | 20 | 2 | 975 | D | |||||||||||||||
10/26/23 17:00 | 10/24/23 | TRML | Health | BioPrd | Biological Products, (No Diag | Kantoff Aaron | NY | D | 1 | P | 89 | 11.86 | 0 | 8 | 20 | 45 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |